Completed
Dolutegravir Expanded Access Study
NCT01536873
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site Fort Lauderdale, Florida, United States